Weihua Guo

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Liver Metastases

Anterior Cruciate Ligament Reconstruction

Ejection Fraction

Top Venues

Research square

Cancer immunology research

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Weihua Guo, Yong Nie ZeYu Huang, Zhao Zhang, Mary A Bucklin, John Martin
Disease progression and clinical outcomes in latent osteoarthritis phenotypes: Data from the Osteoarthritis Initiative. Research square (2024)
Colt A Egelston, Weihua Guo, Diana L Simons, Jian Ye, Christian Avalos, Shawn T Solomon, Mary Nwangwu, Michael S Nelson, Jiayi Tan, Eliza R Bacon, Kena Ihle, Daniel Schmolze, Lusine Tumyan, James R Waisman, Peter P Lee
Organ-specific immune setpoints underlie divergent immune profiles across metastatic sites in breast cancer. Cancer immunology research (2024)
Weihua Guo, Yong Nie ZeYu Huang, Zhao Zhang, Mary A Bucklin, John Martin
Disease progression and clinical outcomes in latent osteoarthritis phenotypes: Data from the Osteoarthritis Initiative. Research square (2024)
Colt A Egelston, Weihua Guo, Diana L Simons, Jian Ye, Christian Avalos, Shawn T Solomon, Mary Nwangwu, Michael S Nelson, Jiayi Tan, Eliza R Bacon, Kena Ihle, Daniel Schmolze, Lusine Tumyan, James R Waisman, Peter P Lee
Organ-specific immune setpoints underlie divergent immune profiles across metastatic sites in breast cancer. Cancer immunology research (2024)
Yong Nie ZeYu Huang, Mary A Bucklin, Weihua Guo, John T Martin
Disease progression and clinical outcomes in latent osteoarthritis phenotypes: Data from the Osteoarthritis Initiative. Research square (2024)
Matthew G Mei, Lu Chen, James K Godfrey, Joo Y Song, Colt A Egelston, L Elizabeth Elizabeth Budde, Saro H Armenian, Liana Nikolaenko, Mary Nwangwu, Weihua Guo, Lei Gao, Peter Lee, Robert W Chen, Shari Daniels, Neena Kennedy, Lacolle Peters, Jasmine Zain, Steven T Rosen, Stephen J Forman, Leslie L Popplewell, Larry W Kwak, Alex F Herrera
Pembrolizumab plus vorinostat is highly active in Hodgkin lymphoma, including patients refractory to prior PD-1 blockade. Blood (2023)
Jian Ye, Weihua Guo, Chongkai Wang, Colt A Egelston, Massimo D'Apuzzo, Geereesh Shankar, Marwan G Fakih, Peter P Lee
Peritumoral immune suppressive mechanisms impede intratumoral lymphocyte infiltration into CRC liver versus lung metastases. Cancer research communications (2023)